18F-FDG PET/CT 与增强 CT 在唾液腺癌分期及预后预测中的比较
研究纳入 67 例连续唾液腺癌患者,术前均行 18F-FDG PET/CT 与增强 CT 并接受手术(可联合术后放化疗)。PET/CT 对颈部转移的敏感性显著高于 CT(P < 0.05),对远处转移两者无差异(P > 0.5);PET/CT 测得的代谢肿瘤体积是 PFS 和 OS 的独立预测因子(均 P < 0.05)。
要点
- PET/CT 对颈部转移的敏感性显著高于增强 CT(P < 0.05)。
- PET/CT 与增强 CT 对远处转移的检出无显著差异(P > 0.5)。
- 代谢肿瘤体积与结外侵犯是 PFS 和 OS 的独立预测因子(均 P < 0.05)。
核心结论
- 在唾液腺癌患者中,18F-FDG PET/CT 检出转移性疾病具有高敏感性和特异性,代谢肿瘤体积有助于预测生存结局。
研究设计与样本
- 纳入 67 例连续唾液腺癌患者,术前前瞻性接受 18F-FDG PET/CT 与增强 CT 评估,随后接受手术,可联合或不联合术后放疗/放化疗。
主要发现
- 67 例中 17 例(25.4%)初诊分期存在颈部转移,4 例(6%)存在远处转移。
- 18F-FDG PET/CT 检出颈部转移的敏感性显著高于 CT(P < 0.05)。
- 18F-FDG PET/CT 与 CT 检出远处转移的敏感性无显著差异(P > 0.5)。
- 区域和远处转移最可靠地由高级别病理分析预测(P < 0.05)。
- 结外侵犯和 18F-FDG PET/CT 测得的代谢肿瘤体积是 PFS 与 OS 的独立预测因子(均 P < 0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Salivary gland carcinoma (SGC) is rare tumor with various histological type and metastatic potential. Pretreatment detection of metastases can contribute to planning the appropriate treatment of SGC. Therefore, the present study evaluated the utility of F-FDG PET/CT versus contrast-enhanced CT for detection of metastases and prediction of outcomes in SGC patients. METHODS: Sixty-seven consecutive SGC patients who were prospectively evaluated by F-FDG PET/CT and contrast-enhanced CT and subsequently underwent surgery with or without postoperative radiotherapy/chemoradiotherapy were included. The diagnostic values of both imaging modalities for detection of metastatic diseases were compared with McNemar test and logistic regression using generalized estimating equations. Cox proportional hazard modeling was used to assess the prognostic values of the quantitative metabolic measurements detected by F-FDG PET/CT and of other clinical factors. RESULTS: Among 67 SGC patients, 17 (25.4%) had cervical metastasis, and 4 (6%) had distant metastasis at initial staging. The sensitivity of F-FDG PET/CT for detection of cervical metastasis was significantly higher than those of CT (P < 0.05), and those of F-FDG PET/CT and CT for detection of distant metastasis did not differ (P > 0.5). Regional and distant site metastases were most reliably predicted by high-grade pathological analysis (P < 0.05). Extranodal extension and metabolic tumor volume measured by F-FDG PET/CT were independent predictors of progression-free survival and overall survival (all P < 0.05). CONCLUSIONS: In SGC patients, F-FDG PET/CT detected metastatic diseases with high sensitivity and specificity, and metabolic tumor volumes helped to predict survival outcomes.
引用
- Park MJ, Oh JS, Roh JL, et al. 18F-FDG PET/CT Versus Contrast-Enhanced CT for Staging and Prognostic Prediction in Patients With Salivary Gland Carcinomas. Clin Nucl Med. 2017. PMID: 28072618. doi:10.1097/RLU.0000000000001515
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。